Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP — Stella

Home/Chronic Rhinosinusitis With Nasal Polyps/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Rhinosinusitis With Nasal Polyps trials

Trial locations(1 site)

Austria

Medical University of Vienna, Vienna, Austria

Key details

Sponsor

Medical University of Vienna

Enrollment target

~80 participants

Started

June 2024

Primary completion

September 2026

Age range

18 Years – 99 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.